New data from the American Cancer Society reveals an alarming trend: younger women are increasingly being diagnosed with breast cancer, prompting calls for earlier screenings.
A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.